NCT02795195View on ClinicalTrials.gov

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 22, 2021

Study Completion Date

April 22, 2021

Conditions
Nasopharyngeal Carcinoma
Interventions
RADIATION

Carbon ion radiotherapy (CIRT)

Five dose levels (51GyE, 54GyE, 57GyE, 60GyE, 63GyE) are planned within the Phase I part. And the started dose level will be 54GyE. Daily fraction of 3 GyE will be delivered for all dose levels. After the recommended dose (RD), i.e., maximal tolerated dose, is determined or if the treatments to 63 GyE are safely delivered, the recommended dose (or 63 GyE) will be the prescribed dose in the Phase II part of the study.

Trial Locations (1)

201321

Shanghai Proton and Heavy Ion Center, Shanghai

All Listed Sponsors
lead

Shanghai Proton and Heavy Ion Center

OTHER

NCT02795195 - Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter